scholarly journals Efficacy and safety of risankizumab in Japanese patients with moderate to severe plaque psoriasis: Results from the Susta IMM phase 2/3 trial

2019 ◽  
Vol 46 (8) ◽  
pp. 686-694 ◽  
Author(s):  
Mamitaro Ohtsuki ◽  
Hideki Fujita ◽  
Mitsunori Watanabe ◽  
Keiko Suzaki ◽  
Mary Flack ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Japanese Patients ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Severe Plaque Psoriasis

scholarly journals Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1)

2017 ◽  
Vol 44 (11) ◽  
pp. 1285-1290 ◽  
Author(s):  
Shinichi Imafuku ◽  
Hitoe Torisu-Itakura ◽  
Atsushi Nishikawa ◽  
Fangyi Zhao ◽  
Gregory S. Cameron ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Subgroup Analysis ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Severe Plaque Psoriasis

scholarly journals Long-term efficacy and safety of secukinumab in Japanese patients with moderate to severe plaque psoriasis: 3-year results of a double-blind extension study

2019 ◽  
Vol 46 (3) ◽  
pp. 186-192 ◽  
Author(s):  
Yukari Okubo ◽  
Mamitaro Ohtsuki ◽  
Akimichi Morita ◽  
Masako Yamaguchi ◽  
Tomohiro Shima ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Japanese Patients ◽  
Extension Study ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Severe Plaque Psoriasis ◽  
Term Efficacy

15328 Efficacy and safety of mirikizumab in patients with moderate to severe plaque psoriasis: 104-week results from a randomized phase 2 study

2020 ◽  
Vol 83 (6) ◽  
pp. AB147
Author(s):  
Robert Bissonnette ◽  
Catherine Maari ◽  
M. Alan Menter ◽  
Chika Ohata ◽  
Kim Alexander Papp ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Severe Plaque Psoriasis ◽  
Phase 2 Study ◽  
Randomized Phase 2
Sign in / Sign up

Export Citation Format

Share Document